Jelena D. Milosevic Feenstra

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan et al. · New England Journal of Medicine · 2013 · 2K citations · Full text

Medicine, Genetics, Hematology +14

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti et al. · Blood · 2013 · 585 citations · Full text

Medicine, Genetics, Hematology +13

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Jelena D. Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger et al. · Blood · 2015 · 273 citations · Full text

Medicine, Genetics, Hematology +15

Loss of <i>Ezh2</i> synergizes with <i>JAK2</i> -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis

Takafumi Shimizu, Lucia Kubovčáková, Ronny Nienhold et al. · The Journal of Experimental Medicine · 2016 · 117 citations · Full text

Life Sciences, Genetics, Hematology +15

Chromothripsis in acute myeloid leukemia: biological features and impact on survival

Maria Chiara Fontana, Giovanni Marconi, Jelena D. Milosevic Feenstra et al. · Leukemia · 2018 · 113 citations · Full text

Life Sciences, Hematology, Oncology +16